bioAffinity Technologies Presents CyPath® Technology at International Lung Cancer Conference
12 avr. 2016 09h00 HE
|
bioAffinity Technologies, Inc.
SAN ANTONIO, April 12, 2016 (GLOBE NEWSWIRE) -- bioAffinity Technologies, a privately held cancer diagnostics company, will present its proprietary technology for the detection of early-stage lung...